Augmentation of adriamycin, melphalan, and cisplatin cytotoxicity in drug-resistant and -sensitive human ovarian carcinoma cell lines by buthionine sulfoximine mediated glutathione depletion.

[1]  M. Winker,et al.  Radiation survival parameters of antineoplastic drug-sensitive and -resistant human ovarian cancer cell lines and their modification by buthionine sulfoximine. , 1985, Cancer research.

[2]  R. Ozols,et al.  Potentiation of melphalan cytotoxicity in human ovarian cancer cell lines by glutathione depletion. , 1984, Cancer research.

[3]  R C Young,et al.  Experimental model systems of ovarian cancer: applications to the design and evaluation of new treatment approaches. , 1984, Seminars in oncology.

[4]  R. Ozols,et al.  Reversal of adriamycin resistance by verapamil in human ovarian cancer. , 1984, Science.

[5]  S. Somfai-Relle,et al.  Glutathione-conferred resistance to antineoplastics: approaches toward its reduction. , 1984, Cancer treatment reviews.

[6]  T. Tsuruo,et al.  Circumvention of vincristine and Adriamycin resistance in vitro and in vivo by calcium influx blockers. , 1983, Cancer research.

[7]  J. Lautenberger,et al.  Cellular genes analogous to retroviral onc genes are transcribed in human tumour cells , 1982, Nature.

[8]  W. Jakoby,et al.  [27] Glutathione S-transferases (rat and human) , 1981 .

[9]  J. Willson,et al.  Cloning of Human Ovarian Cancer Cells in Soft Agar from Malignant Effusions and Peritoneal Washings , 1980 .

[10]  W. Valentine,et al.  Studies on the quantitative and qualitative characterization of erythrocyte glutathione peroxidase. , 1967, The Journal of laboratory and clinical medicine.

[11]  O. H. Lowry,et al.  Protein measurement with the Folin phenol reagent. , 1951, The Journal of biological chemistry.